Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Atsukawa

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
No to Hattatsu = Brain and Development|November 1, 1994
[Epilepsy in patient with structural autosomal abnormality]S Sugama, K Atsukawa, K Kusano, et al.
No to Hattatsu = Brain and Development|February 24, 2001
[A case of multiple sclerosis with recurrent episodes of psychiatric symptoms]S Kawasaki, T Nara, S Hamano, et al.
No to Hattatsu = Brain and Development|July 1, 1994
[Clinical consideration of patients with neonatal bilateral basal ganglia-thalamic lesion due to hypoxic ischemic encephalopathy]S Sugama, K Atsukawa, K Kusano, et al.
Cancer Biochemistry Biophysics|April 1, 1996
Reduction of LAK-sensitivity and changes in antigen expression on hepatoma cells by sodium butyrateS Tada, H Saito, H Ebinuma, et al.
The Keio Journal of Medicine|March 1, 1996
Enhancing effect of the liver extract and flavin adenin dinucleotide mixture on anti-viral efficacy of interferon in patients with chronic hepatitis CH Saito, H Ebinuma, S Tada, et al.
Hepato-Gastroenterology|January 10, 2001
Reduced in vitro immunoglobulin secretion from peripheral blood mononuclear cells in responders to high-dose interferon-alpha 2b treatment for chronic hepatitis CK Atsukawa, H Saito, H Ebinuma, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 12, 2001
Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in ratsT Ohishi, H Saito, K Tsusaka, et al.
The Keio Journal of Medicine|June 1, 1997
Disappearance of serum hepatitis C virus RNA within two days after one dose interferon administration is predictive for response to high-dose interferon-alpha 2b treatment for chronic hepatitis C. Keio Interferon-alpha 2b Study GroupH Saito, H Ebinuma, K Atsukawa, et al.
Hepatology (Baltimore, Md.)|June 1, 1996
Cloning of variable regions of an antibody that reacts with the soluble fraction of human liver cells and its possible value in chronic liver diseaseH Saito, S Tada, H Ebinuma, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 12, 2001
Th1 and Th2 cytokines differentially regulate the transformation of Kupffer cells into multinucleated giant cells but similarly enhance the Kupffer cell-induced hepatic stellate cell proliferationK Atsukawa, H Saito, N Tsukada, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
No to Hattatsu = Brain and Development|November 1, 1994
[Epilepsy in patient with structural autosomal abnormality]S Sugama, K Atsukawa, K Kusano, et al.
No to Hattatsu = Brain and Development|February 24, 2001
[A case of multiple sclerosis with recurrent episodes of psychiatric symptoms]S Kawasaki, T Nara, S Hamano, et al.
No to Hattatsu = Brain and Development|July 1, 1994
[Clinical consideration of patients with neonatal bilateral basal ganglia-thalamic lesion due to hypoxic ischemic encephalopathy]S Sugama, K Atsukawa, K Kusano, et al.
Cancer Biochemistry Biophysics|April 1, 1996
Reduction of LAK-sensitivity and changes in antigen expression on hepatoma cells by sodium butyrateS Tada, H Saito, H Ebinuma, et al.
The Keio Journal of Medicine|March 1, 1996
Enhancing effect of the liver extract and flavin adenin dinucleotide mixture on anti-viral efficacy of interferon in patients with chronic hepatitis CH Saito, H Ebinuma, S Tada, et al.
Hepato-Gastroenterology|January 10, 2001
Reduced in vitro immunoglobulin secretion from peripheral blood mononuclear cells in responders to high-dose interferon-alpha 2b treatment for chronic hepatitis CK Atsukawa, H Saito, H Ebinuma, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 12, 2001
Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in ratsT Ohishi, H Saito, K Tsusaka, et al.
The Keio Journal of Medicine|June 1, 1997
Disappearance of serum hepatitis C virus RNA within two days after one dose interferon administration is predictive for response to high-dose interferon-alpha 2b treatment for chronic hepatitis C. Keio Interferon-alpha 2b Study GroupH Saito, H Ebinuma, K Atsukawa, et al.
Hepatology (Baltimore, Md.)|June 1, 1996
Cloning of variable regions of an antibody that reacts with the soluble fraction of human liver cells and its possible value in chronic liver diseaseH Saito, S Tada, H Ebinuma, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 12, 2001
Th1 and Th2 cytokines differentially regulate the transformation of Kupffer cells into multinucleated giant cells but similarly enhance the Kupffer cell-induced hepatic stellate cell proliferationK Atsukawa, H Saito, N Tsukada, et al.
Pageof 2